semaglutide news today october 2025 Tirzepatide Tops for Weight Loss: SURMOUNT-5 obesity drug news today glp-1

GLP-1 drugs are designed to work at certain doses to achieve optimal receptor saturation

The UK Summary of Product Characteristics warns about diabetic retinopathy complications, especially in patients with existing retinopathy or using insulin

B12 injections are an effective treatment option for replenishing levels quickly and efficiently

Regulatory Exclusivities: The Hidden Barrier Beyond patents, the FDA grants statutory exclusivities that run independently: New Chemical Entity (NCE) Exclusivity: Grants 5 years of data exclusivity for a new active moiety

Spironolactone isnt a weight loss drug

Bydureon BCise, an extended-release version which can be injected once weekly, is approved for use in pediatric patients at least 10 years old and adults with T2D